Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is proud to announce the launch of its D
The Nobel Prize in Physiology or Medicine awarded
This year, the Hamburg based life sciences company
Alembic Pharmaceuticals Ltd., t
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
Eppendorf is proud to announce the launch of its Deepwell Plates BioBased, made from min. 95 % second-generation feedstock (according to mass-balance-approach*). This innovative product represents a significant step forward in sustainable laboratory practices, aligning with Eppendorf’s commitment to environmental stewardship and scientific advancement. The new Deepwell Plates BioBased are designed to meet highest standards of laboratory performance while reducing the carbon footprint associated with traditional plastic labware. All performance features, such as chemical stability, temperature range for usage and centrifugation stability are the same as with fossil based Deepwell plates. By utilizing second-generation feedstock, derived from non-food biomass, Eppendorf ensures that these plates offer an eco-friendly alternative without compromising on quality or efficiency. The launched Deepwell plate comes with 96 wells and a volume of 2mL each well. More formats are in planning.
The product will be available globally starting January 2026.
*For more information about the Deepwell Plates BioBased and mass-balance approach, please visit www.eppendorf.link/biobased
Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world. The product portfolio of the business units Liquid Handling & Consumables, Separation & Instrumentation and Bioprocess includes, for example, pipettes, pipette tips, centrifuges, mixers, ultra-freezers and bioreactors for cell and gene research. In addition, Eppendorf offers a wide range of high-quality consumables. In fiscal year 2024, the Eppendorf Group recorded consolidated revenue of €980.3 million and invested €69 million in research and development (R&D). Eppendorf products are used in academic or industrial research laboratories, such as pharmaceutical, biotech, chemical, and food industries, as well as clinical, environmental, forensic, and industrial laboratories for process analysis, production, and quality assurance.
Since 1945, the Eppendorf Group has been headquartered in Hamburg, Germany, and today operates production and R&D sites in Europe, Asia and North America and has subsidiaries in more than 30 countries. Today, the Group employs around 4,500 people worldwide. They all act in accordance with the purpose of the company’s founders: to improve human living conditions.